Data from 30 years of follow-up of the original Framingham Study cohort of 5,070 men and women aged 30-62 years who were first examined during the period 1948-1952 and who were free of cardiovascular disease reveal that blood pressure is a strong and consistent predictor of the development of coronary heart disease,^slroKe, transient iscnemic attack, and congestive* heartjailurel-Utner'factOTS related 10 blood pressure like obesity, lett ventricular hvpertrojjhv asHemonstrated on electrocardiograms, and heart enlargement as shown by x-ray radiography made several selective additional independent contributions to risk; heart enlargement by x-ray radiography was the best predictor of congestive heart failure. (Hypertension 1989;13(suppl H ypertension is a consistent and modifiable cause of cardiovascular disease. This conclusion is based not only on observational studies, which have shown a significant, strong, consistent, and quantitative relation between blood pressure and various manifestations of cardiovascular disease, 1 but also on intervention studies, which have demonstrated that reduction of blood pressure reduces the risk of cardiovascular disease.
H ypertension is a consistent and modifiable cause of cardiovascular disease. This conclusion is based not only on observational studies, which have shown a significant, strong, consistent, and quantitative relation between blood pressure and various manifestations of cardiovascular disease, 1 but also on intervention studies, which have demonstrated that reduction of blood pressure reduces the risk of cardiovascular disease. 2 -5 With the initial report by Kagan et al in 1958, 6 the Framingham Study has contributed much to the understanding of hypertension as a cardiovascular disease risk factor, and additional understanding has been provided by subsequent studies. 7 -9 This and other evidence has recently been reviewed by Kannel and Stokes. 10 This article summarizes the contribution of blood pressure to the incidence of coronary heart disease (CHD), transient ischemic attacks (TIA), stroke, and congestive heart failure (CHF) based on 30 years of follow-up of the 5,070 men and women of the original Framingham cohort who were found to be free of cardiovascular disease when first examined between 1948 and 1952 and who were then examined biennially during the subsequent 30 years.
Subjects and Methods
The Framingham Study's sampling methods, response rate, and examination techniques and procedures have previously been described in detail by Dawber et al 11 in the book describing the study.
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Surviving subjects were invited for reexamination every 2 years, not only to detect new cardiovascular disease but also to regularly reassess those risk factors suspected of contributing most consistently to risk (e.g., blood pressure). Most subjects had three blood pressures measured at the initial examination and at each subsequent examination. The first of these pressures was recorded by a nurse and the next two by examining physicians. The Framingham Study has traditionally used the first examiner's blood pressure reading in the analyses because that reading was systematically recorded on all subjects and was subject to the least error of measurement. The mean of all three blood pressures has not been used because not all subjects had three blood pressures recorded. Measurement was made in the left arm with the subject sitting. A mercury sphygmomanometer and a 14-cm cuff were used, and readings were recorded to the nearest even number. A thigh cuff was used when required by an arm of large circumference. The fifth (disappearance) Korotkoff sound was used as an index of diastolic pressure unless the sound persisted to zero, in which case the fourth sound was recorded.
Although systolic and diastolic pressures were measured on each occasion, the two pressure-reading curves are so colinear that only one blood pressure measurement can be used for multivariate analysis. Systolic pressure was selected for multivariate analysis because it is subject to the least measurement error and is a more consistent predictor of cardiovascular disease than is diastolic pressure.
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Left ventricular hypertrophy (LVH) was interpreted from an electrocardiogram recorded on a Sanborn Visocardiette with the patient in the recumbent position. Rumholt-Estes criteria were used, and LVH was judged to be borderline if only QRS criteria were met but was considered definite if STand T-wave abnormalities were also apparent.
The cardiovascular outcome criteria used in this study were defined as follows: 1) Subjects were considered to have developed CHD if, when reviewed by three study physicians, they were judged to have one or more of the following manifestations: angina pectoris, coronary insufficiency, myocardial infarction, and sudden or nonsudden death from CHD. Copies of the hospital records were requested whenever the subject reported such an event, as they were for all outcome criteria. 2) A TIA was judged to have occurred if a panel of neurologists agreed that there was a history of a focal neurological deficit lasting less than 24 hours.
3) The minimal criteria for stroke consisted of an abrupt onset of a localized neurological deficit, like hemiparesis, aphasia, or homonomous hemianopsia lasting more than 24 hours. 4) CHF required a minimum of either two major or one major and two minor criteria for CHF agreed on by the panel of three investigators. The major and minor criteria for CHF are listed in Appendix 1.
The Framingham Study invites its subjects for reexamination every 2 years. Therefore, for an independent variable like blood pressure, various analytic options are available. Subjects can be characterized at the initial examination that occurred during the 4-year period 1948-1952, and a proportional-hazards model can then be used for the various outcomes during the next 30 years. All available data of a continuous variable like blood pressure can also be averaged, but this method has not been used because the number of examinations varies from subject to subject, particularly for those dying early in the study or for those developing CHD soon after entry. The method most frequently used has been the pooled cross-sectional method, whereby subjects were characterized at the beginning of a 2-year period and observed for occurrence of any cardiovascular events during the subsequent 2 years. If a subject missed any single examination, the independent variables were assumed to be the same as those measured at the last available examination. In general, this method focuses more on traits than it does on individuals because prior levels of blood pressure and other independent variables do not contribute to this analysis; additionally, the method focuses only on a 2-year period.
The statistical technique used was logistic regression, with coefficients computed by the maximumlikelihood method for each risk factor. These regressions were computed as univariate (i.e., the risk factor as the only independent variable) and as multivariate (i.e., the particular risk factor is included in an analytic model with age, systolic blood pressure, serum cholesterol level, cigarettes smoked per day, glucose intolerance, and LVH). For continuous variables, the actual value of the risk factor was used. The multivariate coefficients were standardized as the product of the maximum-likelihood coefficient from the logistic procedure of the Statistical Analysis System and the standard deviation of the risk factor in the population at risk. Each standardized coefficient measured the change of the logit of risk for each change of one standard deviation of risk variable. The magnitude of the standardized logistic coefficient represents the measure of the contribution of that risk factor to whatever particular manifestation of cardiovascular disease is selected as the dependent variable. The degree of statistical significance (i.e., the p value) also provides another measure of the importance of the risk factor.
Results
As shown in Table 1 , systolic blood pressure exhibits a direct relation with the incidence of CHD; this relation is somewhat stronger for men than it is for women over age 65 years but with a steeper gradient for women under 65 years than for those who developed CHD later in life. Compared with those whose systolic blood pressure is less than 120 mm Hg, the relative risk of those whose systolic blood pressure is greater than 180 mm Hg is more than three for men aged 35-64 years and five for women of the same age stratum. The reverse is true among those aged 65-94 years for whom the male relative risk is almost five and slightly more than three for women. Although the relation weakens somewhat when systolic pressure is entered into a multivariate model with other standard risk factors, nevertheless, the relation remains very highly significant for men and women in both age categories. Table 2 indicates that LVH as demonstrated on the electrocardiogram also independently contributes to the likelihood of developing CHD. However, this variable appears to weigh more heavily and to make a larger independent contribution in the older age group than in those aged 65 years or less. Tables 3 and 4 summarize similar data for stroke and TIA, for which the contribution of blood pressure is even more impressive than it is for CHD. The relative risk of the age-adjusted average annual incidence, comparing those with systolic pressures less than 120 mm Hg to those with pressures of 180 mm Hg or greater, ranges from 3.25 for older men to 8.0 for men aged 35-64 years. The strength of this relation is also reflected in the larger highly significant standardized logistic coefficients in both univariate and multivariate analysis. Surprisingly, LVH, as demonstrated by electrocardiography (Table 4) , appears to be a stronger risk factor for stroke and TLA than it is for CHD, thereby suggesting that LVH may not only represent a summative measure of the level of blood pressure over time but may also provide evidence for a compromised coronary circulation. Tables 5 and 6 demonstrate that there is an equally strong relation of systolic blood pressure and LVH by electrocardiography with the incidence of CHF. For LVH by electrocardiography, the relative risk comparing those with no evidence of LVH to those who meet definite QRS-, ST-, and T-wave criteria is as much as 17 for younger men and women and is 6.4 and 6.7 for men and women, respectively, over age 65 years. However, heart enlargement by chest x-ray radiography is the best predictor of CHF. One reason for this may be due to the fact that other forms of heart disease, for example, valvular congenital cardiomyopathy, may affect only the chest x-ray radiogram and not other manifestations like blood pressure and electrocardiographic abnormalities.
Discussion
These data confirm and emphasize the importance of blood pressure as a risk factor for all three major manifestations of cardiovascular disease. An earlier study by Kannel et al 13 has also reported the importance of blood pressure as a risk factor for atrial fibrillation. The data also confirm that systolic blood pressure is a better predictor than is diastolic pressure, a finding that is consistent with the fact that isolated systolic blood pressure continues to predict the incidence of CHD, stroke, and CHF even for those with diastolic pressures less than 90 mm Hg. The fact that LVH by electrocardiography is an independent contributor to these cardiovascular events suggests that LVH may reflect the severity and duration of hypertension as well as indicate ischemic myocardial involvement. We recognize the hazard of using standardized logistic coefficients to assess the relative importance of risk factors derived from multivariate models. For this reason, we have reported actual rates in the tables, thus making it possible to derive both relative and attributable risks. In the course of this analysis, no major inconsistencies were noted among the standardized logistic coefficients, relative risk, and degree of significance, all of which can be considered measures of risk.
In conclusion, blood pressure is consistently and quantitatively related to the risk of developing CHD, stroke, TIA, and CHF. Other pathogenic traits associated with blood pressure, like obesity, LVH by electrocardiography, and proteinuria, made smaller and less consistent net contributions to such risk.
